temozolomide has been researched along with Debility in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The standard treatment of glioblastoma patients consists of surgery followed by normofractionated radiotherapy (NFRT) with concomitant and adjuvant temozolomide chemotherapy." | 8.12 | Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis. ( Ehret, F; Grosu, AL; Kaul, D; Klement, RJ; Lewitzki, V; Polat, B; Popp, I; Sweeney, RA, 2022) |
| "The standard treatment of glioblastoma patients consists of surgery followed by normofractionated radiotherapy (NFRT) with concomitant and adjuvant temozolomide chemotherapy." | 4.12 | Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis. ( Ehret, F; Grosu, AL; Kaul, D; Klement, RJ; Lewitzki, V; Polat, B; Popp, I; Sweeney, RA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klement, RJ | 1 |
| Popp, I | 1 |
| Kaul, D | 1 |
| Ehret, F | 1 |
| Grosu, AL | 1 |
| Polat, B | 1 |
| Sweeney, RA | 1 |
| Lewitzki, V | 1 |
| Giaccherini, L | 1 |
| Galaverni, M | 1 |
| Renna, I | 1 |
| Timon, G | 1 |
| Galeandro, M | 1 |
| Pisanello, A | 1 |
| Russo, M | 1 |
| Botti, A | 1 |
| Iotti, C | 1 |
| Ciammella, P | 1 |
2 other studies available for temozolomide and Debility
| Article | Year |
|---|---|
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Follow-Up Studies; Frailty; G | 2022 |
Role of multidimensional assessment of frailty in predicting outcomes in older patients with glioblastoma treated with adjuvant concurrent chemo-radiation.
Topics: Age Factors; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy, Adjuvant; | 2019 |